Contract Service Directory

Groupe Parima





Company Headquarters

4450 Cousens
Montreal, QC H4S 1X6
Canada

Company Description

Groupe PARIMA is a CDMO, established in 1994. Over the years, we have developed an expertise in the development and manufacturing of non-sterile liquids, suspensions, and semi-solid pharmaceutical products. This strategic focus has allowed us to establish a unique expertise to support your product development and manufacturing needs, which, combined to our operational flexibility and commitment to delivering on time, enables us to operate as an extension of your team. We have been favorably inspected by the EMA, TMMDA, FDA and Health Canada. We manufacture products for markets around the globe. Our business is 100% fee-for-service and exclusively focused on contract services. We are here to help you meet your company objectives, not to compete with you.

Contract Service Directory

    Related Content


    • Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.
      10.22.19

    • Breaking News
      Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.
      10.18.19


    • Regulatory Affairs | Serialization
      Fighting Back!

      Fighting Back!

      The drug industry takes a bare-knuckle approach to drug counterfeiters.
      Daniela Geiger, Vetter 10.04.19

    • VIDEO: Contract Pharma 2019 Video Highlights!

      VIDEO: Contract Pharma 2019 Video Highlights!

      Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.
      10.02.19

    • Biologics, Proteins, Vaccines | Injectables
      A World of Innovation

      A World of Innovation

      The importance of innovation in the injectable business and the hurdles a CDMO faces
      Claudia Roth, Vetter Pharma-Fertigung GmbH & Co. KG 11.07.17


    • Industry News
      CPhI Report Highlights Anticipated CDMO Market Trends

      CPhI Report Highlights Anticipated CDMO Market Trends

      Niche services and technologies to dominate future acquisitions, increase in flow chemistry, fermentation anticipated
      10.17.17

    • Drug Delivery Innovation

      Growth in biologics is driving advanced drug delivery technology solutions
      Tim Wright, Editor 10.11.17

    • Bio News | Bioanalytical Services | Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      ABL Acquisition Extends Ardena’s Early-phase Offering

      ABL Acquisition Extends Ardena’s Early-phase Offering

      Broadens the CDMO’s pre-clinical and clinical offering to include bioanalytical and drug discovery services.
      10.10.17


    • 2017 Contracting & Outsourcing Conference Wrap up

      2017 Contracting & Outsourcing Conference Wrap up

      Another year of record attendance, sold-out exhibit hall, and sessions addressing key industry topics
      10.06.17

    • Breaking News | Clinical Trial Materials | Drug Development | Industry News
      Ardena Launches following Pharmavize and Crystallics Merger

      Ardena Launches following Pharmavize and Crystallics Merger

      Will offer solid-state chemistry, analytical and formulation development, and early-phase clinical supply manufacturing
      09.11.17

    • Aseptic Processing | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Injectables
      Amatsigroup Manufactures Injectable Clinical Batch Under Single-Use Isolator

      Amatsigroup Manufactures Injectable Clinical Batch Under Single-Use Isolator

      French CDMO develops innovative single-use technology solutions for aseptic formulation & manufacturing
      09.05.17


    • 25	Otsuka

      25 Otsuka

      ...
      07.24.17

    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      Eurofins to Acquire Amatsigroup for $150M

      Eurofins to Acquire Amatsigroup for $150M

      Expands position in biopharmaceutical services
      07.12.17